Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load - PubMed (original) (raw)
. 2004 Aug 15;104(4):942-7.
doi: 10.1182/blood-2003-09-3333. Epub 2004 Apr 29.
Christina M R Kitchen, Lea Liu, Hua Guo, Ron Gascon, Amy B Narváez, Peter Hunt, Jeffrey N Martin, James O Kahn, Jay Levy, Michael S McGrath, Frederick M Hecht
Affiliations
- PMID: 15117761
- DOI: 10.1182/blood-2003-09-3333
Free article
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load
Steven G Deeks et al. Blood. 2004.
Free article
Abstract
Although generalized T-cell activation is an important factor in chronic HIV disease pathogenesis, its role in primary infection remains poorly defined. To investigate the effect of immune activation on T-cell changes in subjects with early HIV infection, and to test the hypothesis that an immunologic activation "set point" is established early in the natural history of HIV disease, a prospective cohort of acutely infected adults was performed. The median density of CD38 molecules on CD4+ and CD8+ T cells was measured longitudinally in 68 antiretroviral-untreated individuals and 83 antiretroviral-treated individuals. At study entry, T-cell activation was positively associated with viremia, with CD8+ T-cell activation levels increasing exponentially at plasma HIV RNA levels more than 10,000 copies/mL. Among untreated patients, the level of CD8+ T-cell activation varied widely among individuals but often remained stable within a given individual. CD8+ T-cell activation and plasma HIV RNA levels over time were independently associated with the rate of CD4+ T-cell loss in untreated individuals. These data indicate that immunologic activation set point is established early in HIV infection, and that this set point determines the rate at which CD4+ T cells are lost over time.
Similar articles
- The independent effect of drug resistance on T cell activation in HIV infection.
Hunt PW, Deeks SG, Bangsberg DR, Moss A, Sinclair E, Liegler T, Bates M, Tsao G, Lampiris H, Hoh R, Martin JN. Hunt PW, et al. AIDS. 2006 Mar 21;20(5):691-9. doi: 10.1097/01.aids.0000216369.30948.18. AIDS. 2006. PMID: 16514299 - Close association of CD8+/CD38 bright with HIV-1 replication and complex relationship with CD4+ T-cell count.
Tuaillon E, Al Tabaa Y, Baillat V, Segondy M, Picot MC, Reynes J, Vendrell JP. Tuaillon E, et al. Cytometry B Clin Cytom. 2009 Jul;76(4):249-60. doi: 10.1002/cyto.b.20467. Cytometry B Clin Cytom. 2009. PMID: 19072838 - Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy.
Benito JM, López M, Lozano S, Ballesteros C, Martinez P, González-Lahoz J, Soriano V. Benito JM, et al. J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):373-81. doi: 10.1097/01.qai.0000153105.42455.c2. J Acquir Immune Defic Syndr. 2005. PMID: 15764953 - HIV-1-specific cytolytic T-lymphocyte activity correlates with lower viral load, higher CD4 count, and CD8+CD38-DR- phenotype: comparison of statistical methods for measurement.
Lubaki NM, Shepherd ME, Brookmeyer RS, Hon H, Quinn TC, Kashamuka M, Johnson M, Gottle R, Devers J, Lederman HM, Bollinger RC. Lubaki NM, et al. J Acquir Immune Defic Syndr. 1999 Sep 1;22(1):19-30. doi: 10.1097/00042560-199909010-00003. J Acquir Immune Defic Syndr. 1999. PMID: 10534143 - HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome.
Soghoian DZ, Jessen H, Flanders M, Sierra-Davidson K, Cutler S, Pertel T, Ranasinghe S, Lindqvist M, Davis I, Lane K, Rychert J, Rosenberg ES, Piechocka-Trocha A, Brass AL, Brenchley JM, Walker BD, Streeck H. Soghoian DZ, et al. Sci Transl Med. 2012 Feb 29;4(123):123ra25. doi: 10.1126/scitranslmed.3003165. Sci Transl Med. 2012. PMID: 22378925 Free PMC article.
Cited by
- Gut dendritic cell activation links an altered colonic microbiome to mucosal and systemic T-cell activation in untreated HIV-1 infection.
Dillon SM, Lee EJ, Kotter CV, Austin GL, Gianella S, Siewe B, Smith DM, Landay AL, McManus MC, Robertson CE, Frank DN, McCarter MD, Wilson CC. Dillon SM, et al. Mucosal Immunol. 2016 Jan;9(1):24-37. doi: 10.1038/mi.2015.33. Epub 2015 Apr 29. Mucosal Immunol. 2016. PMID: 25921339 Free PMC article. - A novel web-based risk calculator for predicting surgical site infection in HIV-positive facture patients: a multicenter cohort study in China.
Liu B, Wei G, Hu L, Zhang Q. Liu B, et al. Front Cell Infect Microbiol. 2024 Jun 26;14:1408388. doi: 10.3389/fcimb.2024.1408388. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38988810 Free PMC article. - Latent and Active Tuberculosis Infection Increase Immune Activation in Individuals Co-Infected with HIV.
Sullivan ZA, Wong EB, Ndung'u T, Kasprowicz VO, Bishai WR. Sullivan ZA, et al. EBioMedicine. 2015 Apr 1;2(4):334-340. doi: 10.1016/j.ebiom.2015.03.005. EBioMedicine. 2015. PMID: 26114158 Free PMC article. - CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure.
Okoye AA, Picker LJ. Okoye AA, et al. Immunol Rev. 2013 Jul;254(1):54-64. doi: 10.1111/imr.12066. Immunol Rev. 2013. PMID: 23772614 Free PMC article. Review. - Dissociation of CD154 and cytokine expression patterns in CD38+ CD4+ memory T cells in chronic HIV-1 infection.
Espinosa E, Ormsby CE, Reyes-Terán G, Asaad R, Sieg SF, Lederman MM. Espinosa E, et al. J Acquir Immune Defic Syndr. 2010 Dec;55(4):439-45. doi: 10.1097/QAI.0b013e3181ef991d. J Acquir Immune Defic Syndr. 2010. PMID: 20926955 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials